Public health and valorization of genome-based technologies: a new model

BACKGROUND: The success rate of timely translation of genome-based technologies to commercially feasible products/services with applicability in health care systems is significantly low. We identified both industry and scientists neglect health policy aspects when commercializing their technology, m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lal, Jonathan A, Schulte in den Bäumen, Tobias, Morré, Servaas A, Brand, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296632/
https://www.ncbi.nlm.nih.gov/pubmed/22142533
http://dx.doi.org/10.1186/1479-5876-9-207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296632/
https://www.ncbi.nlm.nih.gov/pubmed/22142533
http://dx.doi.org/10.1186/1479-5876-9-207

Ejemplares similares